Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Damage Dna”

169 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 169 results

Early research (Phase 1)Study completedNCT01051635
What this trial is testing

A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas

Who this might be right for
NeoplasmsLymphoma
National Cancer Institute (NCI) 55
Not applicableUnknownNCT05138302
What this trial is testing

A Clinical Study of BRCA and DNA Damage Repair Genes in Blood Samples of Chinese Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
RenJi Hospital 1,000
Not applicableStudy completedNCT00864955
What this trial is testing

Cutaneous DNA Damage Caused by UV-A Irradiation

Who this might be right for
Healthy Volunteers
University Hospital, Grenoble 24
Not applicableStudy completedNCT04372914
What this trial is testing

Prevention of Oral DNA Damage by Black Raspberries

Who this might be right for
Oral CancerSmokingDNA Damage+1 more
Milton S. Hershey Medical Center 69
Early research (Phase 1)Study completedNCT01445522
What this trial is testing

ABT-888 Plus Metronomic Cyclophosphamide to Treat Cancer

Who this might be right for
NeoplasmsLymphoma
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT04019327
What this trial is testing

The Drugs Talazoparib and Temozolomide in Prostate Cancer

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstate Neoplasm+2 more
Memorial Sloan Kettering Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT01989546
What this trial is testing

Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations

Who this might be right for
Advanced Ovarian CancerPrimary Peritoneal CancerAdvanced Breast Cancer+1 more
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Looking for participantsNCT05933265
What this trial is testing

Study of LP-184 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorGBM+4 more
Lantern Pharma Inc. 175
Testing effectiveness (Phase 2)Study completedNCT02032251
What this trial is testing

Reduction of Sperm DNA Fragmentation by Oral Ginger

Who this might be right for
Infertility
Royan Institute 71
Not applicableStudy completedNCT02954120
What this trial is testing

Chronic Periodontitis and Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary SyndromeChronic Periodontitis
Bezmialem Vakif University 88
Early research (Phase 1)WithdrawnNCT06719973
What this trial is testing

Phase 1 Study of M9466 Combined With Carboplatin and Platinum-based Anticancer Therapy (DDRiver 521)

Who this might be right for
Advanced Solid Tumors
EMD Serono Research & Development Institute, Inc.
Testing effectiveness (Phase 2)Study completedNCT01677169
What this trial is testing

Effect of Noni Juice on Lipid Peroxidation-derived DNA Adducts in Heavy Smokers

Who this might be right for
DNA Damage
Tahitian Noni International, Inc. 317
Not applicableStudy completedNCT03250715
What this trial is testing

Effects of Low Level Laser Therapy on Functional Capacity and DNA Damage of Patients With Chronic Kidney Failure

Who this might be right for
Low-Level Light TherapyRenal Insufficiency, ChronicRenal Dialysis+1 more
Federal University of Health Science of Porto Alegre 28
Not applicableStudy completedNCT01038024
What this trial is testing

Study for the Liquid Chromatography-mass Spectrometry (LC-MS/MS) Assessment of Oxidative DNA Damage in Relation to Antioxidant Usage

Who this might be right for
Cancer
Roswell Park Cancer Institute 38
Early research (Phase 1)Study completedNCT03030417
What this trial is testing

Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas

Who this might be right for
Solid TumorsLymphoma
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Ended earlyNCT03810105
What this trial is testing

Olaparib and Durvalumab in Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 5
Very early researchWithdrawnNCT06246786
What this trial is testing

Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)

Who this might be right for
Triple Negative Breast CancerDNA Damage Repair Deficiency
Virginia G. Kaklamani
Not applicableStudy completedNCT04032275
What this trial is testing

Correlation Between Virus and Biochemical Characteristics and Liver Histological Damage in Untreated Chronic HBV Infection

Who this might be right for
Chronic Hepatitis B
Beijing Ditan Hospital 400
Not applicableEnded earlyNCT00493376
What this trial is testing

Study of Tumour Response to Tirapazamine During Treatment of Cervical Cancer

Who this might be right for
Cervix Cancer
British Columbia Cancer Agency 1
Early research (Phase 1)Study completedNCT02723864
What this trial is testing

Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors

Who this might be right for
Neoplasms
National Cancer Institute (NCI) 53
Load More Results